These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge. Tao T, Skiadopoulos MH, Durbin AP, Davoodi F, Collins PL, Murphy BR. Vaccine; 1999 Mar 05; 17(9-10):1100-8. PubMed ID: 10195620 [Abstract] [Full Text] [Related]
18. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. White LJ, Parsons MM, Whitmore AC, Williams BM, de Silva A, Johnston RE. J Virol; 2007 Oct 05; 81(19):10329-39. PubMed ID: 17652394 [Abstract] [Full Text] [Related]
19. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A. Virology; 1998 Nov 10; 251(1):28-37. PubMed ID: 9813200 [Abstract] [Full Text] [Related]
20. Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. Lee MS, Mendelman PM, Sangli C, Cho I, Mathie SL, August MJ. J Infect Dis; 2001 Apr 15; 183(8):1281-4. PubMed ID: 11262213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]